Specialty Pharmacy

Preventative measures emphasized to reduce transmission of disease.

Top stories of the week on Specialty Pharmacy Times from June 22-26.

Patients with a burn injury were twice as likely to have been prescribed oxygen in the previous 90 days.

Study finds improved screening needed for condition.

Pharmacists can play a role in improving patient understanding of health insurance.

Topical medications stimulated the regeneration of damaged brain cells.

Early research in HIV and hepatitis B discontinued.

Drugs like Viagra previously thought to increase risk of malignant melanoma.

Treating patients within 3 months of the onset of symptoms may prove to be beneficial.

Court votes 6-3 in favor of upholding legislation.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group discusses how the Affordable Care Act has emphasized the importance of specialty pharmacy services.

Study finds that Medicare Part D cost saving projections are based on flawed methodology.

Small molecule agent able to detect or destroy prostate cancer cells when combined with different radionuclides.

Gaining approval from insurance companies for highly effective new hepatitis C virus treatments is fraught with challenges for patients.

Advocacy group staffed by hepatitis C patients helps others find hope in fight against the disease.

New hepatitis C drugs moved the dream of a cure into a reality that gives patients a new chance at life.

Researchers discuss mechanism for overcoming resistance to drugs that target BRAF protein.

Oregon allows pharmacists to be reimbursed for performing clinical pharmacy services.

Pharmacists can reassure patients taking pre-exposure prophylaxis that the human immunodeficiency virus prevention treatment will not increase their risk for depression.

Increasing immune cell infiltration into tumors induces the immune system to block tumor growth.

Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how the specialty pharmacy landscape will evolve in the coming years.

Sandoz has begun shipping glatiramer acetate (Glatopa), the first FDA-approved generic competitor to Teva's Copaxone multiple sclerosis (MS) drug.

Hyperlipidemia found to alter immune response.

Top stories of the week on Specialty Pharmacy Times from June 15 to June 19.

Vitamin D may play a role in maintaining intestinal barrier.

Allegations include conspiracy to commit health care fraud, violations of the anti-kickback statutes, money laundering, and aggravated identity theft.

Patients achieve drug-free remission with less expensive biologic drugs during first 2 years of treatment.

Lipid from avocados targets leukemia stem cells.